Pacific Edge Limited (PFGTF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 26.06 Million NZD | -51.76% |
| 2023 | 54.03 Million NZD | 45.26% |
| 2022 | 18.54 Million NZD | 41.01% |
| 2021 | 13.15 Million NZD | 20.15% |
| 2020 | 10.94 Million NZD | -40.0% |
| 2019 | 18.24 Million USD | -7.47% |
| 2018 | 19.72 Million USD | -14.24% |
| 2017 | 22.99 Million USD | 177.87% |
| 2016 | 8.27 Million USD | -5.82% |
| 2015 | 8.78 Million NZD | 34.48% |
| 2014 | 6.53 Million NZD | 224.53% |
| 2013 | 2.01 Million NZD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 7.65 Million USD | -48.17% |
| 2024 Q2 | 7.47 Million USD | 105.63% |
| 2024 FY | 46.19 Million NZD | 71.43% |
| 2024 Q4 | 8.24 Million USD | 28.27% |
| 2024 Q3 | 6.79 Million USD | -58.13% |
| 2023 FY | 26.94 Million NZD | 45.26% |
| 2023 Q4 | 7.73 Million USD | -1.5% |
| 2023 Q3 | 7.85 Million USD | 68.45% |
| 2023 Q2 | 4.66 Million USD | 0.0% |
| 2022 FY | 18.54 Million NZD | 41.01% |
| 2022 Q2 | 8.67 Million USD | 0.0% |
| 2022 Q4 | 10.1 Million USD | 0.0% |
| 2021 Q2 | 5.66 Million USD | 0.0% |
| 2021 FY | 13.15 Million NZD | 20.15% |
| 2021 Q4 | 7.41 Million USD | 0.0% |
| 2020 Q2 | 5.91 Million USD | 0.0% |
| 2020 Q4 | 5.61 Million USD | 0.0% |
| 2020 FY | 10.94 Million NZD | -40.0% |
| 2019 FY | 18.24 Million USD | -7.47% |
| 2018 FY | 19.72 Million USD | -14.24% |
| 2017 FY | 22.99 Million USD | 177.87% |
| 2016 FY | 8.27 Million USD | -5.82% |
| 2015 FY | 8.78 Million NZD | 34.48% |
| 2014 FY | 6.53 Million NZD | 224.53% |
| 2013 FY | 2.01 Million NZD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -2384.495% |
| Arrayit Corporation | 6.19 Million USD | -320.525% |
| Atlantic International Corp. | 5.57 Million USD | -367.212% |
| Biocept, Inc. | 29.4 Million USD | 11.356% |
| Bioqual, Inc. | 7.44 Million USD | -249.888% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -3275.332% |
| DermTech, Inc. | 104.01 Million USD | 74.944% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 84.347% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | -15.199% |
| iMD Companies, Inc. | 151.8 Thousand USD | -17067.86% |
| IDenta Corp. | 662.97 Thousand USD | -3831.122% |
| Interpace Biosciences, Inc. | 20.23 Million USD | -28.817% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -66931.085% |
| InVitro International | 661.32 Thousand USD | -3840.936% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -267.179% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -44748.493% |
| Medical Imaging Corp. | 1.91 Million USD | -1262.977% |
| NovelStem International Corp. | 3.53 Million USD | -636.683% |
| Optigenex Inc. | 1.28 Million USD | -1923.681% |
| PharmChem, Inc. | 2.93 Million USD | -789.127% |
| Proteome Sciences plc | 3.26 Million USD | -697.502% |
| Response Genetics, Inc | 25.31 Million USD | -2.936% |
| Rennova Health, Inc. | 7.67 Million USD | -239.451% |
| RushNet, Inc. | 1.78 Million USD | -1356.551% |
| ScreenPro Security Inc. | 3.23 Million USD | -704.664% |
| Stella Diagnostics Inc. | 11.42 Million USD | -128.078% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -254.927% |
| Todos Medical Ltd. | 14.05 Million USD | -85.392% |